Literature DB >> 3342475

Vasa vasorum in atherosclerotic coronary arteries: responses to vasoactive stimuli and regression of atherosclerosis.

J K Williams1, M L Armstrong, D D Heistad.   

Abstract

The goals of this study were to determine whether vasa vasorum in atherosclerotic coronary arteries respond to vasoactive stimuli and to examine effects of regression of atherosclerosis on blood flow through vasa vasorum in coronary arteries. We studied three groups of monkeys: normal, atherosclerotic, and regression. Blood flow to vasa vasorum was measured with microspheres. Blood flow to intima-media (ml/min x 100 g) was 5 +/- 1 (mean +/- SEM) in normal and 47 +/- 7 in atherosclerotic monkeys (p less than 0.05). Infusion of phenylephrine or serotonin did not alter flow through vasa in normal monkeys. In atherosclerotic monkeys, phenylephrine decreased flow through vasa vasorum in intima-media of coronary arteries to 24 +/- 4 (p less than 0.05), and serotonin decreased flow to 27 +/- 5 (p less than 0.05). In regression monkeys, blood flow to intima-media was sixfold less (7 +/- 2 ml/min x 100 g) than in atherosclerotic monkeys (p less than 0.05). During infusion of adenosine, blood flow to vasa was fourfold greater in atherosclerotic monkeys than after regression of atherosclerosis. This finding suggests that loss of vessels, not constriction of existing vessels, accounts for the decrease in flow through vasa in intima-media after regression of atherosclerosis. We conclude that vasa vasorum in atherosclerotic coronary arteries respond to vasoconstrictor stimuli and that there is loss of vasa vasorum and a large decrease in blood flow through vasa to intima-media of coronary arteries after regression of atherosclerosis.

Entities:  

Mesh:

Year:  1988        PMID: 3342475     DOI: 10.1161/01.res.62.3.515

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  22 in total

1.  Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.

Authors:  M Kaiser; B Younge; J Björnsson; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 2.  Evaluation of microvascular anatomy by micro-CT.

Authors:  A Lerman; E L Ritman
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

Review 3.  The dynamic vasa vasorum.

Authors:  Erik L Ritman; Amir Lerman
Journal:  Cardiovasc Res       Date:  2007-06-29       Impact factor: 10.787

Review 4.  Protective vascular and myocardial effects of adiponectin.

Authors:  Barry J Goldstein; Rosario G Scalia; Xin L Ma
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-11-25

Review 5.  Animal models of atherosclerosis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

6.  Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis.

Authors:  Karen S Moulton; Khashayar Vakili; David Zurakowski; Mohsin Soliman; Catherine Butterfield; Erik Sylvin; Kin-Ming Lo; Stephen Gillies; Kashi Javaherian; Judah Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

Review 7.  Serum-derived growth factor is thrombin?

Authors:  S M Schwartz
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

8.  Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis.

Authors:  C F Moyer; D Sajuthi; H Tulli; J K Williams
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

Review 9.  Anti-angiogenic activity of rPAI-1(23) and vasa vasorum regression.

Authors:  Mary Jo Mulligan-Kehoe
Journal:  Trends Cardiovasc Med       Date:  2013-01-11       Impact factor: 6.677

10.  Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.

Authors:  Mark Slevin; Jerzy Krupinski; Lina Badimon
Journal:  J Angiogenes Res       Date:  2009-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.